Sosei Heptares Webinar Presentation for FY2022 Financial Results
Sosei Heptares Webinar Presentation for FY2022 Financial Results - read this article along with other careers information, tips and advice on BioSpace
Stay updated with breaking news from Sosei Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sosei Heptares Webinar Presentation for FY2022 Financial Results - read this article along with other careers information, tips and advice on BioSpace
PF-07081532 is the first clinical candidate from multi-target drug discovery collaboration to advance into Phase 2 trialsDosing of first subject in Phase 2...
New agreement leverages Sosei Heptares’ GPCR-focused structure-based drug design capabilities and Lilly’s extensive development, commercialization and...
TOKYO and CAMBRIDGE, United Kingdom, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in G...
/PRNewswire/ -- Global techbio company PrecisionLife, pioneers in precision medicine for chronic diseases, will assess the precision medicine potential of a...